• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

S2Medical

0.01 SEK

+3.70 %

Less than 1K followers

S2M

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+3.70 %
-20.00 %
-44.55 %
-47.66 %
-47.17 %
-71.28 %
-95.93 %
-99.56 %
-99.84 %

S2Medical operates in the medical technology sector. The company is focused on research and development of various wound healing products. Various products offered include cellulose-based materials and dressings for the healing of burns and chronic wounds. The products are sold under various brands, mainly at a European level. S2Medical was founded in 2013 and is headquartered in Linköping.

Read more
Market cap
5.25M SEK
Turnover
4K SEK
Revenue
14.36M
EBIT %
-18.54 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
21.8
2026

Interim report Q2'26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release6/20/2024, 8:32 AM

S2Medical AB: Epiprotect® Demonstrates Significantly Lower Infection Risk in Major Pediatric Study

S2Medical
Regulatory press release11/6/2023, 3:09 PM

S2Medical AB (publ) Signs Exclusive Distribution Agreement with Provas Medical Ltd for the Turkish Market

S2Medical
Regulatory press release8/25/2023, 1:30 PM

S2Medical AB: INTERIM REPORT APRIL - JUNE 2023

S2Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release7/5/2023, 6:45 AM

S2Medical AB (publ) announces final outcome in the company's rights issue

S2Medical
Regulatory press release7/4/2023, 8:21 AM

S2Medical AB Secures New Loan Agreement and Aims to be Debt-Free by July 2024

S2Medical
Regulatory press release7/3/2023, 4:26 PM

S2Medical AB: S2Medical (publ) announces preliminary outcome in the company's rights issue

S2Medical
Regulatory press release6/16/2023, 11:45 AM

S2Medical AB (publ) publishes a prospectus regarding the rights issue

S2Medical
Regulatory press release6/8/2023, 3:15 PM

S2Medical AB (publ) signs a manufacturing agreement with a distributor in Saudi Arabia

S2Medical
Regulatory press release5/31/2023, 5:00 PM

S2Medical AB: Interim Report January - March 2023

S2Medical
Regulatory press release5/17/2023, 11:33 AM

S2Medical AB (publ) signs a distribution agreement for the Iranian market

S2Medical
Regulatory press release5/16/2023, 2:45 PM

S2Medical AB: S2Medical wins procurement for wound healing items in the Västra Götaland region

S2Medical
Regulatory press release5/10/2023, 9:34 AM

S2Medical AB: Postponing of publication of the quarterly report for the period January to March 2023

S2Medical
Regulatory press release4/24/2023, 3:09 PM

S2Medical AB: Postponement of publication of annual report

S2Medical
Regulatory press release4/21/2023, 1:37 PM

S2Medical AB: S2Medical wins procurement for wound healing items in the United Arab Emirates worth approximately SEK 3.4 million

S2Medical
Regulatory press release4/13/2023, 9:32 AM

S2Medical AB (publ) signs a distributor agreement in the United Arab Emirates and delivers a record order of the skin substitute Epiprotect worth about SEK 2 million

S2Medical
Regulatory press release3/28/2023, 2:36 PM

S2Medical AB: S2Medical implements a strategic change to reach profitability faster

S2Medical
Regulatory press release3/3/2023, 11:39 AM

S2Medical AB: S2Medical wins procurement for wound healing equipment in Region Halland

S2Medical
Regulatory press release2/22/2023, 2:45 PM

Year-end report January - December 2022 S2Medical AB (publ)

S2Medical
Regulatory press release2/16/2023, 4:44 PM

S2Medical AB: Postponing of publication of the year-end report

S2Medical
Regulatory press release1/2/2023, 4:15 PM

S2Medical AB: Positive outcome when S2Medicals antimicrobial peptides were tested against the multi resistant bacteria that by WHO have been defined as a global health threat

S2Medical